Nominee Director Duties & Liability for AIF-Appointed Board Representatives
When an Alternative Investment Fund invests in a portfolio company, board representation is almost always part of the deal. The fund nominates a director — often a partner, principal, or investment professional from the fund manager — to sit on the investee's board and protect the fund's interests from the inside. It sounds straightforward until the nominee director realises a basic, uncomfortable truth of Indian company law: once appointed, they owe their duty to the company, not to the fund that put them there.
This gap between who appoints a director and who that director legally serves is where most of the real risk in board representation sits.
Who Is a Nominee Director, Legally
Under the Companies Act, 2013, a nominee director is a director nominated by an institution in pursuance of a contract, or by the Central or State Government, or appointed by any institution or by any other person under a shareholders' agreement to represent its interests. AIFs typically secure this right through a shareholders' agreement (SHA) or investment agreement executed at the time of investment, which contractually obligates the investee company to appoint the fund's nominee to its board — usually for as long as the fund holds a minimum shareholding threshold.
The Act treats a nominee director largely like any other director for the purpose of duties, with one important carve-out discussed below.
The Core Tension: Duty to the Company vs. Loyalty to the Fund
Section 166 of the Companies Act, 2013 codifies director duties, and it applies to nominee directors exactly as it does to any other board member:
- Act in good faith to promote the objects of the company for the benefit of its members as a whole
- Act in the best interests of the company, its employees, shareholders, and the community, and for the protection of the environment
- Exercise duties with reasonable care, skill, and diligence
- Not involve the company in a situation where the director has a direct or indirect interest that conflicts, or possibly may conflict, with the company's interest
- Not achieve or attempt to achieve undue gain or advantage, either for themselves or their relatives, partners, or associates None of this says "except where instructed by the appointing fund." A nominee director cannot simply vote as instructed by the AIF if doing so is against the interests of the company as a whole — this is precisely the trap. The nominee owes the company primary loyalty, even though the fund pays their firm's fees and expects them to protect the fund's investment.
Where This Actually Bites
The tension is mostly academic until the portfolio company hits distress, or a decision arises where the fund's interest and the company's interest genuinely diverge — for example:
- A down round where existing shareholders (including the fund) benefit from terms that dilute other stakeholders unfairly
- A related-party transaction between the portfolio company and another entity in the fund's broader portfolio
- A decision to pursue a strategy that maximises short-term exit value for the fund at the expense of the company's longer-term health
- Insolvency-adjacent decisions, where directors' duties shift toward creditors under the Insolvency and Bankruptcy Code, 2016, and a nominee director voting purely to protect the fund's downside can expose themselves personally In each of these, a nominee director who simply does what the fund wants — without independently assessing whether it's in the company's interest — is not fulfilling their statutory duty, and is personally exposed if things go wrong.
Personal Liability Exposure
Nominee directors face the same liability framework as any other director, including:
- Civil liability for breach of fiduciary duty under Section 166
- Liability for oppression and mismanagement claims under Sections 241–242, if minority shareholders allege the board (including the nominee) acted against the company's interests
- Liability under the IBC if found to have contributed to wrongful trading or failed to act once the company was in the zone of insolvency
- Liability under SEBI regulations, where applicable — for instance, if the nominee director is also privy to unpublished price-sensitive information as a connected person under the SEBI (Prohibition of Insider Trading) Regulations, 2015, and that information flows back to the fund
- Signing liability on statutory filings, board resolutions, and certifications the director executes in their capacity as a board member — this doesn't disappear because the director was "just representing the fund's interest" One narrow degree of comfort: Indian courts and the MCA have generally recognised that a nominee director acting bona fide, exercising independent judgment, and not simply rubber-stamping the appointing entity's instructions, is treated the same as any other non-executive director for liability purposes — the nominee label itself does not automatically increase or decrease liability. The risk arises specifically when the nominee director abdicates independent judgment.
How AIFs Structure Around This Risk in Practice
Indemnification in the Investment Agreement
Most SHAs include an indemnity from the portfolio company (and sometimes the founders) in favour of the nominee director for actions taken in good faith in that capacity. This does not eliminate statutory liability to regulators, but it does address the company's own claims against the director and often covers legal costs of defending third-party claims.
Directors & Officers (D&O) Insurance
A well-negotiated investment agreement will make D&O insurance a condition of the fund's board appointment right — the portfolio company procures and maintains a policy covering the nominee director from day one, not after a dispute has already arisen.
Observer Rights as an Alternative
Where the fund wants information and influence but wants to avoid the fiduciary exposure of a board seat entirely, board observer rights are increasingly used, particularly for smaller check sizes or earlier-stage investments. An observer typically has the right to attend and speak at board meetings but not to vote, and — depending on how the right is drafted — may sit outside the strict fiduciary duty framework that binds appointed directors. This is not a guaranteed shield (poorly drafted observer rights can still create de facto director liability under the "shadow director" or "deemed director" concepts), but it is a meaningfully different risk profile when structured correctly.
Clear Internal Governance on Voting
Sophisticated fund managers give their nominee directors an internal mandate that explicitly separates "representing the fund's information interests" from "voting as instructed" — the nominee is expected to exercise independent judgment at the board table, escalate genuine conflicts internally rather than resolve them unilaterally, and abstain (with a documented reason) rather than vote against the company's interest under fund pressure.
What Founders and Portfolio Companies Should Also Know
This isn't a one-sided risk conversation. Founders negotiating board composition should understand that a nominee director genuinely cannot be compelled to vote a particular way by the fund without exposing that director — which, perhaps counterintuitively, is a protection for the company. It also means portfolio companies should extend indemnification and D&O coverage to nominee directors on the same terms as any other board member, both because it's the right governance practice and because a fund reluctant to secure that coverage for its nominee is a signal worth noticing during negotiation.
FAQs on Nominee Director Duties
Can a nominee director be removed by the AIF at will?
Generally yes, if the shareholders' agreement grants the fund an unrestricted right to nominate and replace its board representative — this is standard in most AIF investment agreements and doesn't itself create liability issues, since it operates through the company's own appointment/removal machinery under the Companies Act rather than bypassing it.
Does a nominee director have to disclose instructions received from the fund?
There is no blanket statutory requirement to disclose informal instructions, but a nominee director must disclose any interest that conflicts or may conflict with the company's interest under Section 184 of the Companies Act, and should recuse from voting on matters where such a conflict genuinely exists.
Is a nominee director personally liable for the portfolio company's debts?
Not automatically. Directors are not personally liable for company debts in the ordinary course — that is the basic principle of limited liability. Personal liability arises in specific circumstances: fraud, wrongful trading once insolvency is reasonably foreseeable, personal guarantees separately signed, or statutory penalties for specific compliance failures (like certain tax or labour law defaults) that attach to "officers in default."
Should an AIF always insist on a board seat rather than observer rights?
Not necessarily — it depends on check size, stage, and how much active governance influence the fund genuinely needs versus how much fiduciary exposure it's willing to accept. Larger, control-oriented investments typically warrant a board seat; smaller minority checks in early-stage companies increasingly use observer rights to get information access with a lighter liability footprint.
This article is intended for general informational purposes and does not constitute legal advice. Nominee director liability depends heavily on the specific facts, the drafting of the shareholders' agreement, and the circumstances of any dispute — consult your legal advisor before relying on any general principle discussed here for a specific board appointment.
Anuj Desai & Associates advises AIFs and portfolio companies on board representation structuring, shareholders' agreements, and nominee director governance frameworks. [Talk to an advisor] to discuss your fund's board appointment strategy.